Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 1: An overview

被引:148
作者
Hureau, Christelle [1 ,2 ]
机构
[1] CNRS, Chim Coordinat Lab, F-31077 Toulouse, France
[2] Univ Toulouse, UPS, INPT, LCC, F-31077 Toulouse, France
关键词
Amyloid; Copper; Iron; APP; Binding sites; Bioinorganic chemistry; COPPER-BINDING DOMAIN; A-BETA; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; RADICAL GENERATION; HYDROGEN-PEROXIDE; INDUCED TOXICITY; FIBER FORMATION; CU(II) BINDING; SENILE PLAQUE;
D O I
10.1016/j.ccr.2012.03.037
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Metal ions, mainly copper, zinc and iron, have been involved in several processes associated with the etiology of Alzheimer disease (AD). Amyloid deposits found in AD patients' brains, known as senile plaques, are one of the morphological hallmarks of this neurodegenerative disorder. They are mostly constituted of aggregated and fibrillar forms of amyloid-beta (A beta) peptides but also contain high concentrations of metal ions (in the mM range). Because the A beta peptide in its monomeric soluble form exist in healthy patients, step(s) in the process leading to the formation of the senile plaques is(are) key for the A beta neurotoxicity. A beta is obtained by specific cleavage of the Amyloid Precursor Protein (APP). Both A beta peptides and APP contain metal ions binding sites and metal ions coordination may impact their intrinsic properties. For instance, in the case of A beta peptides, metal ions modulate A beta aggregation propensity and redox properties of redox active ions such as copper and iron are altered by binding to A beta. The main objective of the present review is to give an overview of the structural evidence available nowadays concerning coordination to APP and A beta peptides of redox active ions, i.e. copper(I/II) and iron(II/III). Copper(II) site in the so-called copper binding site of APP was determined by X-ray crystallography and is {N-im(tau)(His147)N-im(pi)(His151), PhO-(Tyr168), 2O(water)}. More recently, in APP, a copper(II) site made of four imidazole rings from His outside the copper binding domain was characterized by X-ray diffraction. Two copper(II) sites in A beta co-exist at physiological pH, noted components I and 11, where I (resp. II) is predominant at lower (resp. higher) pH. Inland II, the equatorial binding sites of copper(II) are {-NH2 (Asp1), CO (Asp1-Ala2), N-im (His6), N-im (His13 or His14),} and {-NH2 (Asp1), N- (Asp1-Ala2), CO (Ala2-Glu3), N-im (His6 or His13 or His14)}, respectively. Copper(I) is linearly bound to A beta via two imidazole rings from the His residues. Such highly different environments of copper in its two redox states impact the properties of the copper redox couple and will be briefly commented on in the present review. Regarding iron binding to APP and A beta, preliminary data, which essentially show that iron(II) is the sole redox state able to interact with APP and A beta, are described. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:2164 / 2174
页数:11
相关论文
共 156 条
[91]   Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio [J].
Kuperstein, Irina ;
Broersen, Kerensa ;
Benilova, Iryna ;
Rozenski, Jef ;
Jonekheere, Wim ;
Debulpaep, Maja ;
Vandersteen, Annelies ;
Segers-Nolten, Ine ;
Van der Werf, Kees ;
Subramaniam, Vinod ;
Braeken, Dries ;
Callewaert, Geert ;
Bartic, Carmen ;
D'Hooge, Rudi ;
Martins, Ivo Cristiano ;
Rousseau, Frederic ;
Schymkowitz, Joost ;
De Strooper, Bart .
EMBO JOURNAL, 2010, 29 (19) :3408-3420
[92]   Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease [J].
Leskovjan, Andreana C. ;
Kretlow, Ariane ;
Lanzirotti, Antonio ;
Barrea, Raul ;
Vogt, Stefan ;
Miller, Lisa M. .
NEUROIMAGE, 2011, 55 (01) :32-38
[93]  
Linder Maria C., 1996, American Journal of Clinical Nutrition, V63, p797S
[94]   Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation [J].
Liu, Beinan ;
Moloney, Aileen ;
Meehan, Sarah ;
Morris, Kyle ;
Thomas, Sally E. ;
Serpell, Louise C. ;
Hider, Robert ;
Marciniak, Stefan J. ;
Lomas, David A. ;
Crowther, Damian C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (06) :4248-4256
[95]   Copper, iron and zinc in Alzheimer's disease senile plaques [J].
Lovell, MA ;
Robertson, JD ;
Teesdale, WJ ;
Campbell, JL ;
Markesbery, WR .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 158 (01) :47-52
[96]   Copper(I) and copper(II) binding to β-amyloid 16 (Aβ16) studied by electrospray ionization mass spectrometry [J].
Lu, Yu ;
Prudent, Michel ;
Qiao, Liang ;
Mendez, Manuel A. ;
Girault, Hubert H. .
METALLOMICS, 2010, 2 (07) :474-479
[97]   Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents [J].
Mandel, Silvia ;
Amit, Tamar ;
Bar-Am, Orit ;
Youdim, Moussa B. H. .
PROGRESS IN NEUROBIOLOGY, 2007, 82 (06) :348-360
[98]   ALUMINUM, IRON, AND ZINC IONS PROMOTE AGGREGATION OF PHYSIOLOGICAL CONCENTRATIONS OF BETA-AMYLOID PEPTIDE [J].
MANTYH, PW ;
GHILARDI, JR ;
ROGERS, S ;
DEMASTER, E ;
ALLEN, CJ ;
STIMSON, ER ;
MAGGIO, JE .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (03) :1171-1174
[99]   Overexpression of Alzheimer's disease amyloid-β opposes the age-dependent elevations of brain copper and iron [J].
Maynard, CJ ;
Cappai, R ;
Volitakis, I ;
Cherny, RA ;
White, AR ;
Beyreuther, K ;
Masters, CL ;
Bush, AI ;
Li, QX .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) :44670-44676
[100]   MRI and Histological Analysis of Beta-Amyloid Plaques in Both Human Alzheimer's Disease and APP/PS1 Transgenic Mice [J].
Meadowcroft, Mark D. ;
Connor, James R. ;
Smith, Michael B. ;
Yang, Qing X. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 29 (05) :997-1007